RetinalGenix Technologies (RTGN) Non-cash Items (2020 - 2026)
RetinalGenix Technologies (RTGN) reported Non-cash Items of $481276.0 for Q1 2026, up 20.31% on a YoY basis from $400037.0 in Q1 2025, and down 2.75% sequentially from $494908.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Non-cash Items (2020 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 7 years of Non-cash Items data on file, last reported at $481276.0 in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 20.31% year-over-year to $481276.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 2.27% YoY), and the FY2025 full-year result was $1.9 million, down 47.74% from the prior year.
- Non-cash Items fell to $481276.0 in Q1 2026, from $494908.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $2.4 million in Q3 2022 to a low of $228333.0 in Q2 2023.
- A 5-year average of $663784.9 and a median of $481276.0 in 2026 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items soared 622.8% in 2022 and tumbled 79.82% in 2025, its largest moves.
- Tracing RTGN's Non-cash Items over 5 years: stood at $641721.0 in 2022, then sank by 60.79% to $251611.0 in 2023, then surged by 170.51% to $680637.0 in 2024, then declined by 27.29% to $494908.0 in 2025, then slipped by 2.75% to $481276.0 in 2026.
- Business Quant data shows RTGN's Non-cash Items at $481276.0 in Q1 2026, $494908.0 in Q4 2025, and $464954.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 481,276.00 |
| Mar 31, 2026 | 481,276.00 |
| Dec 31, 2025 | 494,908.00 |
| Dec 31, 2025 | 494,908.00 |
| Sep 30, 2025 | 464,954.00 |
| Sep 30, 2025 | 464,954.00 |
| Jun 30, 2025 | 510,346.00 |
| Jun 30, 2025 | 510,346.00 |
| Mar 31, 2025 | 400,037.00 |
| Mar 31, 2025 | 400,037.00 |
| Dec 31, 2024 | 680,637.00 |
| Dec 31, 2024 | 680,637.00 |
| Sep 30, 2024 | 397,359.00 |
| Sep 30, 2024 | 397,359.00 |
| Jun 30, 2024 | 518,838.00 |
| Jun 30, 2024 | 518,838.00 |
| Mar 31, 2024 | 1.98 Mn |
| Mar 31, 2024 | 1.98 Mn |
| Dec 31, 2023 | 251,611.00 |
| Dec 31, 2023 | 251,611.00 |